The European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by Moderna, the second COVID-19 vaccine authorised in the EU.
Related Documents
- Publication date
- 6 January 2021
- Author
- Directorate-General for Health and Food Safety